Caris Life Sciences
Fulfilling the promise of precision medicine through quality and innovation.
1649 employees · est. 1996 · Irving, United States
Tempus AI
Tempus AI, Inc. (NASDAQ: TEM) is a technology company leading the adoption of AI to advance precision medicine.
3104 employees · est. 2015 · Chicago, United States
Caris Life Sciences is the older company (1996 vs 2015).
Side-by-Side Comparison
| Metric | Caris Life Sciences | Tempus AI |
|---|---|---|
| Founded | ||
| Founded | 1996 older | 2015 |
| Headquarters | ||
| Headquarters | Irving, United States | Chicago, United States |
| Employees | ||
| Employees | 1649 | 3104 |
| Industry | ||
| Industry | Not tracked yet | AI, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Unknown | Post Ipo Debt |
| Total Funding | ||
| Total Funding | $2.11B | $1.64B |
| Funding Rounds | ||
| Funding Rounds | 6 | 15 |
| Services | ||
| Services | Molecular Profiling, AI-Powered Interpretation, Comprehensive Genomic Testing, Blood and Tissue-Based Profiling, Clinical Outcome Data Collection, Multimodal Data Analysis | AI-Enabled Healthcare Solutions, Diagnostic Tools Development, Healthcare Data Analytics, Research Program Partnerships |
| Target Customers | ||
| Target Customers | Cancer Patients, Oncologists, Biopharma Companies, Clinical Researchers | Healthcare Providers, Research Institutions, Medical Professionals, Healthcare Researchers |
| Taxonomy | ||
| Taxonomy | Precision Medicine, TechBio, Molecular Profiling, Whole Exome Sequencing, Whole Transcriptome Sequencing, Clinico-genomic Database, Cancer Patient Outcomes, Genomics, Diagnostics, Theranostics, Comprehensive Genomic Profiling, Big Data In Healthcare, Therapy Selection | Precision Medicine, Multimodal Data, Clinical Data Interpretation, Molecular Data Analysis, Personalized Patient Care, Therapeutics Development, AI-Enabled Healthcare Solutions, Patient Data Utilization, Healthcare Operating Systems, Medical Data Libraries, Healthcare Innovation |
| Website | ||
| Website | carislifesciences.com | tempus.com |
About Caris Life Sciences
Caris Life Sciences, established in 1996, stands at the forefront of TechBio innovations, leading the charge in precision medicine. The company’s commitment to harnessing quality and innovation is evident through their proprietary molecular profiling techniques, notably Whole Exome and Whole Transcr...
About Tempus AI
Tempus AI, Inc. (NASDAQ: TEM) is at the forefront of integrating artificial intelligence into the healthcare sector, emphasizing the power of precision medicine. Since its founding in 2015, Tempus has focused on building one of the largest libraries of multimodal medical data globally, ensuring that...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Caris Life Sciences and Tempus AI — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Caris Life Sciences and Tempus AI — by email.
Frequently Asked Questions
Compare Caris Life Sciences with someone else
Start typing a company name or domain.